Head of Global Development and Clinical Operations, Pharmaceuticals Research & Development, Bayer
Christoph is Head of Global Development and Clinical Operations, Pharmaceuticals Research & Development, at Bayer, where he oversees the clinical development of the entire portfolio including executing clinical studies globally. He joined Bayer from Otsuka where, as Chief Medical Officer, he oversaw the entire development organization including Clinical Pharmacology and Translational Medicine, clinical development and operations, Drug Safety, Regulatory Affairs and Quality, Data Management and Analytics, Real-World and Value Evidence, Technical Operations, Medical Affairs, as well as portfolio and asset management.
Before joining Otsuka in 2019, Christoph was Head of Cardiovascular Medicine and Development at Bristol-Meyers Squibb (BMS), helping to develop its next generation of cardiovascular medicines. Prior to his role at BMS, Christoph worked for Novo Nordisk in various medical and development functions in Europe, as well as in the U.S. Christoph’s medical background has informed his ability to combine scientific innovation with a strategic approach to business development opportunities, regulatory navigation, and global patient access solutions.
Christoph received his medical degree from Ruprecht-Karls University School of Medicine in Heidelberg, Germany, in 1994. He also holds an MBA from Schiller International University and is board certified in internal medicine and diabetology.